While I agree with some that the announcement is a little vague in the sense it doesn't give us clear guidance about how the trial is really going, my final interpretation is similar to Blane and Smokey - I interpreted this to mean the trial is going well. The way I figure it is that there is little point in expanding the number of trial sites if patient 6 went worse than expected, which they would definitely know by now. Also agree with Blane that the "dosing is proceeding well" implies patient 7 and 8 have probably been dosed. I finally had the guts to buy more today. I've been thinking about it for a while at these prices, but this announcement made me think it was worth the punt.
- Forums
- ASX - By Stock
- Ann: FOURTH SITE IN HEPATITIS C CLINICAL TRIAL
While I agree with some that the announcement is a little vague...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online